Adjunct Associate Professor of Pathology
Adjunct Associate Professor of Urology
[email protected]
Available to mentor
Scott A Tomlins
Adjunct Associate Professor
-
Center MemberTaubman Institute
-
Center MemberCenter for Computational Medicine and Bioinformatics
-
Center MemberRogel Cancer Center
-
Thomas SP, Vaishampayan UN, Johnson B, Lamb LE, Mowers J, Bulen BJ, Khazanov NA, Hovelson DH, Kwiatkowski K, Rhodes DR, Tomlins SA. Journal of Clinical Oncology, 2024 Feb 1; 42 (4_suppl): 467 - 467.Journal ArticleDevelopment and validation of a tumor tissue based multivariate biomarker for predicting angiogenesis inhibitor clinical benefit in renal cell carcinoma (RCC).
DOI:10.1200/jco.2024.42.4_suppl.467 -
Suga J, Thomas S, Achacoso N, Jiang C, Chung E, Solorzano-Pinto A, Tse P, Bulen BJ, Khazanov NA, Lamb LE, Hovelson DH, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA, Habel LA. Journal of Thoracic Oncology, 2023 Nov; 18 (11): s238 - s239.Journal ArticleP1.21-11 Immunotherapy Response Score (IRS) Predicts Pembrolizumab Clinical Benefit in Patients with NSCLC in TPS≥50%
DOI:10.1016/j.jtho.2023.09.397 -
Tosoian JJ, Sessine MS, Trock BJ, Ross AE, Xie C, Zheng Y, Samora NL, Siddiqui J, Niknafs Y, Chopra Z, Tomlins S, Kunju LP, Palapattu GS, Morgan TM, Wei JT, Salami SS, Chinnaiyan AM. Prostate Cancer Prostatic Dis, 2023 Sep; 26 (3): 563 - 567.Journal ArticleMyProstateScore in men considering repeat biopsy: validation of a simple testing approach.
DOI:10.1038/s41391-022-00633-3 PMID: 36585434 -
Tomlins S. 2023 Aug 10;PresentationTranslating the Cancer Genome & Transcriptome to the Clinic
-
Bulen BJ, Khazanov NA, Hovelson DH, Lamb LE, Matrana M, Burkard ME, Yang ES-H, Edenfield WJ, Claire Dees E, Onitilo AA, Buchschacher GL, Miller AM, Parsons BM, Wassenaar TR, Suga JM, Siegel RD, Irvin W, Nair S, Slim JN, Misleh J, Khatri J, Masters GA, Thomas S, Safa MM, Anderson DM, Mowers J, Dusenbery AC, Drewery S, Plouffe K, Reeder T, Vakil H, Patrias L, Falzetta A, Hamilton R, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA. Cancer Res Commun, 2023 Jul; 3 (7): 1335 - 1349.Journal ArticleValidation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
DOI:10.1158/2767-9764.CRC-23-0036 PMID: 37497337 -
Vuong W, Ganguly S, Balyimez A, Halima A, Kerr C, Day ML, Tomlins SA, Grivas P, Gupta S, Chan TA-T, Jha B, Mian OY. Journal of Clinical Oncology, 2023 Jun 1; 41 (16_suppl): e16622 - e16622.Journal ArticleDifferentiating bladder cancer (BLCA) tumor immune microenvironment (TME) profiles based on predicted intrinsic radiosensitivity (RS).
DOI:10.1200/jco.2023.41.16_suppl.e16622 -
Thomas SP, Achacoso N, Jiang C, Chung E, Solorzano-Pinto AV, Tse P, Bulen BJ, Khazanov NA, Lamb LE, Hovelston DH, Kwiatkowski K, Johnson DB, Rhodes DR, Tomlins SA, Suga JM, Habel LA. Journal of Clinical Oncology, 2023 Jun 1; 41 (16_suppl): e14646 - e14646.Journal ArticleEvaluation of immunotherapy response score (IRS) for predicting pembrolizumab (pembro) clinical benefit in patients (pts) with advanced solid tumors.
DOI:10.1200/jco.2023.41.16_suppl.e14646 -
Mehra R, Shah T, Liu C-J, Plouffe KR, Wang X, Mannan R, Cao X, Chinnaiyan AM, Tomlins SA, Udager AM. Mod Pathol, 2023 Jun; 36 (6): 100146Journal ArticleHighly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification.
DOI:10.1016/j.modpat.2023.100146 PMID: 36828361